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Original Article
Pancreaticoduodenectomy with External Drainage of
the Pancreatic Remnant
Suvit Sriussadaporn, Rattaplee Pak-art, Sukanya Sriussadaporn, Kritaya Kritayakirana and 
Supparerk Prichayudh, Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
OBJECTIVE: Leakage of the pancreaticojejunal anastomosis is a serious complication after pancreati-
coduodenectomy. External drainage of the pancreatic remnant is one of several methods for reducing
pancreaticojejunal anastomotic leakage or fistula. We investigated complications after pancreaticoduo-
denectomy with and without external drainage of the pancreatic remnant.
METHODS: Patients who underwent pancreaticoduodenectomy at King Chulalongkorn Memorial
Hospital, Bangkok, Thailand from November 1991 to October 2007 were enrolled. Before 2001, no external
pancreatic drainage was employed during pancreaticojejunal anastomosis (non-stented group). Since
2001, external drainage of the pancreatic remnant has been routinely performed with a paediatric feeding
tube (stented group). 
RESULTS: There were 28 patients in the non-stented group and 45 in the stented group. Stented patients
had undergone significantly more previous abdominal operations, pylorus preserving pancreaticoduo-
denectomy, and end to end anastomosis of the pancreatic remnant and jejunal limb. Leakage of the 
pancreaticojejunal anastomosis or pancreatic fistula, overall complications, and re-laparotomy rate 
were significantly higher in the non-stented group (leakage or fistula 21.4% vs. 6.7%, overall complications
50% vs. 33.3%, and re-laparotomy 18% vs. 2.2%). The only death was in the non-stented group.
CONCLUSION: External drainage of the pancreatic remnant after pancreaticoduodenectomy is an effec-
tive method for prevention of pancreaticojejunal anastomosis leakage and other related complications.
[Asian J Surg 2008;31(4):167–73]
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anastomotic leakage
Introduction
Pancreaticoduodenectomy (PD) was first successfully 
performed and reported by Kausch in Berlin in 1912.1
In 1935, Whipple et al popularized this complex proce-
dure and reported three patients with carcinoma of the
ampulla of Vater who had undergone PD.2 Until 1980, the
operative mortality was relatively high, ranging from 17%
to 23% in some large series.3–5 With increasing experience
and advances in medical and surgical technology, the
mortality rate has dramatically decreased to less than 5%,
but the overall morbidity is still high at 25–50%.6–11
Amongst a long list of complications currently recog-
nized after PD, leakage of the pancreaticojejunal anas-
tomosis and pancreatic fistula are the most dangerous.
The incidence has been 8–20% in recent studies.6–11
Although the majority of patients with pancreatic fistulae
can be successfully treated by conservative means, serious
consequences such as bleeding and severe intra-abdominal
infection may occur.6–8,12–14 Furthermore, delayed gastric
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emptying, re-laparotomy, prolonged hospital stay, and in-
creasing hospital costs are also unwanted related sequelae.
One of the major aims of PD is to establish proper
management of the pancreatic remnant. Prevention of pan-
creaticojejunal anastomotic failure following PD has been
attempted with several modifications of the surgical tech-
niques. Amongst them, external drainage of the pancreatic
remnant has been practiced and reported with satisfac-
tory outcomes.15–18 The basic concept of draining the pan-
creatic enzymes away from the jejunal limb to promote
healing of the anastomosis is attractive, especially in cen-
tres with low or medium surgical capacity for these complex
operative procedures. We have added external drainage of
the pancreatic remnant in patients who underwent PD
since 2001. This change began after we encountered a
patient with fatal haemorrhage from leakage of the pan-
creaticojejunal anastomosis in what should have been an
uneventful PD in late 2000. The idea that draining the pan-
creatic enzymes out of the body would minimize the risk of
pancreaticojejunal anastomotic leakage and subsequent
complications inspired us to undertake the present study.
The purpose of the present study was to examine the
occurrence of complications in patients who underwent
PD before and after external pancreatic drainage.
Patients and methods
Patients who had undergone pancreaticoduodenectomy
with external drainage of the pancreatic remnant from
January 2001 to October 2007 were compared prospectively
with those who had undergone the same operation without
external drainage from November 1991 to December 2000.
All operations were performed by Suvit Sriussadaporn 
at King Chulalongkorn Memorial Hospital, Bangkok,
Thailand.
Surgery was performed in almost exactly the same way
in all patients. In brief, after the surgical specimen was 
removed, the jejunum was brought through the retro-
mesenteric route to form an anastomosis with the pancre-
atic remnant and bile duct. Then, the gastric remnant (in
classical PD) or first part of the duodenum (in pylorus-
preserving PD) was anastomosed to the jejunum in an
antecolic, end-to-side fashion.19 Before 2001, reconstruc-
tion of the pancreaticojejunal anastomosis was performed
without using an external pancreatic drainage (non-stented
group). Since 2001, external pancreatic drainage has been
added during reconstruction of the pancreaticojejunal
anastomosis (stented group). Most of the anastomoses
were performed using the end-to-end method (21 of 28
non-stented and all stented patients). The end-to-end
pancreaticojejunal anastomosis was performed by invagi-
nating the cut end of the pancreatic remnant, approxi-
mately 2 cm in length, into the end of the jejunal limb.
The end of the jejunal limb was fixed to the pancreatic pa-
renchyma with an interrupted 3-0 polypropylene suture.
External pancreatic drainage was created by using a pae-
diatric polyvinyl chloride feeding tube. This was inserted
into the pancreatic duct as a stent, and brought out
through the jejunal and abdominal wall, and connecting
to a reservoir (urine bag) (Figure). The stent was secured
Figure. Illustration demonstrating methods of reconstruction of the pancreaticobilioduodenal or gastrojejunal anastomosis after
pancreaticoduodenectomy, with insertion of the external pancreatic stent: (A) in pylorus-preserving pancreaticoduodenectomy; 
(B) in classical Whipple operation.
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to the pancreatic stump with two 5-0 absorbable sutures,
and was pulled out 3–4 weeks later when the anchoring
sutures dissolved. If there was any resistance during re-
moval of the stent, the procedure was aborted and
repeated 2 weeks later until successful. Most external pan-
creatic stents were removed at the outpatient clinic. The
size of the pancreatic stents used depended on the size of
the pancreatic ducts. A number 3, 5 or 8 French paediatric
feeding tube was used for a small, medium or large pan-
creatic duct, respectively.
Two Penrose drains were routinely placed at the 
subhepatic area and Morrison’s pouch. Prophylactic
antibiotics were routinely administered. The patients
received no postoperative octreotide to prevent pancreati-
cojejunal anastomotic leakage. Pancreaticojejunal anas-
tomotic leakage was diagnosed from operative findings
at re-laparotomy. Pancreatic fistula was diagnosed when
drainage fluid from Penrose drains contained amylase
more than three times the serum amylase level after post-
operative day 3, as suggested by the International Study
Group on Pancreatic Fistula (ISGPF).20
Demographic data, details of operations, operative find-
ings of the texture of the pancreatic remnant and size of the
pancreatic duct, and postoperative complications of both
groups of patients were compared using the χ2, Fisher’s
exact and Student’s t tests. Comparison of the qualitative
data (i.e. gender, texture of the pancreatic remnant, etc.)
was performed with the χ2 or Fisher’s exact test as appro-
priate. Comparison of the quantitative data (i.e. age, oper-
ation time, etc.) was performed with the Student’s t test.
A value of p < 0.05 was considered statistically significant.
Results
There were 28 patients in the non-stented and 45 in the
stented group. The age ranged from 21 to 92 years (mean,
61.4; median, 63). Forty-three patients (58.9%) were male
and 30 (41.1%) were female. The age, gender, urgency of
operation, pathological diagnosis, texture of the pancre-
atic remnant, size of the pancreatic duct, operative time,
operative blood transfusion, death rate, and hospital stay
did not differ significantly between the two groups of
patients. The stented group had a significantly higher
number of patients with a history of previous abdominal
surgery (18 vs. 3 in the non-stented group), pylorus-
preserving operation (34 vs. 11 in the non-stented group),
and reconstruction of the pancreaticojejunal anastomosis
using the end-to-end method (45 vs. 21 in the non-stented
group) (Tables 1–3).
Three uncomplicated pancreatic fistulae occurred in
the stented patients, and leakage and fistulae occurred in
six of the non-stented patients. Five patients in the non-
stented group underwent re-laparotomy, with one death.
There was only one re-laparotomy and no deaths in the
stented patients. Indications for re-laparotomy in the non-
stented patients were: massive bleeding after leakage of
the pancreaticojejunal anastomosis in one patient (died);
intra-abdominal collection of abscesses, with sepsis in two
patients; obstruction of the gastrojejunal anastomosis in
one patient; and stricture of the choledochojejunal anas-
tomosis in one patient. The indication for re-laparotomy in
the only patient in the stented group was intra-abdominal
abscess collection and sepsis. Patients who had asympto-
matic pancreatic fistulae (biochemical leakage with raised
amylase levels in the drainage fluid, but no clinical symp-
toms) were all successfully treated by conservative man-
agement. This included maintenance of oral intake,
protection of the skin from the digestive action of drainage
fluid, and shortening of the Penrose drains at 2–3 weeks
after the occurrence of pancreatic fistula, when the fistula
tract was established. Leakage of the pancreaticojejunal
anastomosis or pancreatic fistula, overall complications,
and the re-laparotomy rate were significantly higher in
the non-stented group (leakage or fistula 21.4% vs. 6.7%,
overall complications 50% vs. 33.3%, and re-laparotomy
18% vs. 2.2%).
In patients who had external drainage of the pancre-
atic remnant (stented group), 24 (53.3%) had fibrotic pan-
creatic parenchyma and 21 (47.7%) had normal pancreas
(Table 3). The pancreatic ducts were dilated (> 3 mm
diameter) in 26 patients (57.8%). One (2.2%), 18 (40%) and
26 (57.8%) patients were stented with a paediatric feeding
tube of size 3, 5 and 8 French, respectively. The pancreatic
drainage volume from the external stent ranged from
80 mL to 600 mL/day (mean, 225 ± 114; median, 200).
Duration of pancreatic stenting ranged from 15 to 107 days
(mean, 37 ± 20; median, 35).
Discussion
Leakage of pancreaticojejunal anastomosis has long been
recognized as a concern for surgeons who perform PD.
Complications at or around the pancreaticojejunal anas-
tomosis are the most frequent and dangerous following
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PD.12 Subsequent haemorrhage after these complications
may be fatal.13,14 Several methods of constructing the
pancreaticojejunal anastomosis have been advocated,
none of which can completely eliminate the possibility of
leakage. We had a patient who succumbed to massive
bleeding after leakage of the pancreaticojejunal anasto-
mosis following PD in late 2000. Since then, we have
added an external pancreatic stent to drain the pancreatic
remnant and have encountered fewer problems with the
pancreaticojejunal anastomosis. Although we could not
completely eliminate the occurrence of pancreatic fistu-
lae, the incidence of this complication in the stented
patients was remarkably low (6.7%). All three pancreatic
fistulae in the stented patients were uncomplicated, with
an output of 30–50 mL/day. The fistula was spontaneously
closed within 2 weeks, whilst the external pancreatic stent
was draining 200–300 mL/day of pancreatic juice. Fur-
thermore, these minor pancreatic fistulae were treated
successfully without parenteral nutritional support, and
oral intake was maintained until the fistulae were sponta-
neously closed. Our study has confirmed the advantage of
draining the pancreatic juice out of the body. The stented
patients had a significantly lower rate of pancreatic stump
problems and overall complications. Only one patient
underwent re-laparotomy for intra-abdominal collection
of abscesses since the introduction of external drainage of
the pancreatic remnant. In our opinion, prevention of
pancreaticojejunal anastomosis leakage following PD is
an important means to prevent other related complica-
tions such as pancreatic fistula, intra-abdominal infec-
tion, intra-abdominal bleeding, delayed gastric emptying,
and wound infection.
Table 1. Demographic data
External pancreatic drainage
No (n = 28) Yes (n = 45)
p
Age, yr NS*
Mean 60 ± 48 63 ± 16
Median 65 63
Range 21–84 33–92
Gender NS†
Male 16 27
Female 12 18
Previous abdominal operation 3 18 < 0.05‡
Elective operation 28 43 NS‡
Urgency of operation
Emergency operation 0 2
Type of operation < 0.05†
Classical Whipple 17 11
PPPD 11 34
Pancreaticojejunal anastomosis < 0.05‡
End to side 7 0
End to end 21 45
Pathological diagnosis NS†
Ca ampulla of Vater 15 14
Ca head of the pancreas 5 12
Ca distal common bile duct 2 5
Ca duodenum 2 1
Other malignancies 2 6
Other benign conditions 2 7
*Student’s t test; †χ2 test; ‡Fisher’s exact test. NS = not significant; PPPD = pylorus-preserving pancreaticoduodenectomy.
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The idea of using an external pancreatic stent to pre-
vent pancreaticojejunal anastomotic leakage can be traced
back to the early days of PD.21,22 The underlying reasons
supporting the usefulness of an external pancreatic stent
to protect the pancreaticojejunal anastomosis can be
explained simply. Firstly, draining the pancreatic enzymes
from the pancreaticojejunal anastomotic area prevents
the digestive action of the remnant pancreas. Secondly,
decompressing the jejunal limb results in lowering the
tension at the anastomotic site which creates a better
environment for healing. Thirdly, stenting of the pancre-
atic duct allows more precise placement of sutures during
pancreaticojejunal anastomosis.18 In our experience, the
pancreatic ducts were found easily in all patients, without
the need to stimulate pancreatic secretion by intravenous
administration of secretin, as recommended by some in-
vestigators.16 All except one normal pancreatic duct could
be stented with a number 5 French paediatric feeding
tube. The remaining normal pancreatic duct was stented
with a number 3 French paediatric feeding tube. All dilated
pancreatic ducts that were associated with chronic pan-
creatic fibrosis were stented with a number 8 French tube.
Some investigators have shown that the rate of pancreati-
cojejunal anastomotic leakage or pancreatic fistula is
high in patients with soft, fragile, normal pancreatic
parenchyma.15,23,24 Ohwada et al have recommended the
use of external pancreatic stents in patients with small
pancreatic ducts (< 2 mm in diameter).25 Although anas-
tomosis of the jejunal limb to the fibrotic pancreatic
parenchyma in patients with a dilated pancreatic duct is
Table 2. Operative data and outcomes
External pancreatic drainage
No (n = 28) Yes (n = 45)
p
Operative time, min NS*
Mean 480 ± 115 452 ± 93
Median 480 420
Range 270–705 300–780
Operative blood transfusion, units NS*
Mean 3.7 ± 2.4 4.2 ± 2.3
Median 3.5 3
Range 0–12 0–7
Complications < 0.05†
Leakage of pancreaticojejunal anastomosis or 6 (21.4%) 3 (6.7%)
pancreatic fistula
Wound infection 2 5
Bile fistula 0 2
Intra-abdominal collection 2 1
Delayed gastric emptying 2 2
Gastric outlet obstruction 2 0
Acute coronary syndrome 0 1
Gastrointestinal bleeding 0 1
Overall complications 14 (50%) 15 (33.3%) < 0.05‡
Re-laparotomy 5 (17.9%) 1 (2.2%) < 0.05†
Death 1 (3.6%) 0 NS†
Hospital stay, d NS*
Mean 27.5 ± 20.6 27.5 ± 14.6
Median 23 21.5
Range 10–92 11–73
*Student’s t test; †Fisher’s exact test; ‡χ2 test.
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claimed to be safe and seems to remove the need for exter-
nal pancreatic drainage, we still suggest insertion of an
external pancreatic stent in all patients to minimize the
risk of pancreatic leakage.
Our treatment outcomes in patients who had external
pancreatic drainage were obviously superior to those
without external drainage, in terms of leakage of the pan-
creaticojejunal anastomosis, overall complications, and
re-laparotomy rate. External drainage is performed using
a simple paediatric polyvinyl chloride feeding tube, which is
inexpensive and readily available in all hospitals. No com-
plications related to the stent itself or method of stent inser-
tion were observed in our patients. In addition, we did not
administer postoperative octreotide to decrease pancre-
atic enzyme secretion and protect the pancreaticojejunal
anastomosis as suggested by some investigators.20,26,27 We
believe that external drainage of pancreatic enzymes with
a pancreatic stent is undoubtedly adequate, and the need
to use this costly somatostatin analogue can be avoided.
In our study, the operative time of the non-stented and
stented patients did not differ significantly. This supports
the advantage of stent insertion in view of the simplicity
of the procedure. Furthermore, we strictly emphasized
careful and meticulous surgical techniques that resulted
in a relatively prolonged operative time (mean of 480 ±
115 minutes in the non-stented and 452 ± 33 minutes in
the stented patients). We would like to stress that, apart
from external drainage of the pancreatic remnant, a fault-
less operative procedure enhances the outcome.19
The hospital stay of patients in our study was rela-
tively prolonged, with a median of more than 3 weeks in
both non-stented and stented patients. The explanations
for this prolonged hospital stay may be as follows. Firstly,
some patients came from rural areas and had low socio-
economic status, and we decided that early discharge might
be harmful. Secondly, some patients were reluctant to go
back home with an external pancreatic drain and waited
for drain removal before discharge. Thirdly, we had a sig-
nificant number of elderly patients (58% aged > 60 years,
30% > 70 years, and 12% > 80 years), and prolonged hospi-
tal stay was necessary in some of these patients. The dura-
tion of external pancreatic drainage was also relatively
prolonged (median, 35 days). Theoretically, the external
pancreatic drain can be safely removed when patients con-
sume a regular diet, without pancreatic fistula. However,
since we emphasized the security of the drain to the pan-
creatic stump during the early postoperative period, and
used two anchoring stitches of 5-0 absorbable suture, we
Table 3. Comparison of pancreatic texture and size of pancreatic duct and details of stented patients
Non-stented patients, n (%) Stented patients, n (%)
p*
(n = 28) (n = 45)
Pancreatic texture NS
Normal parenchyma 12 (42.9%) 21 (46.7%)
Chronic fibrotic pancreas 16 (57.1%) 24 (53.3%)
Pancreatic duct NS
Normal size (2–3 mm diameter) 13 (46.4%) 19 (42.2%)
Dilated (> 3 mm diameter) 15 (53.6%) 26 (57.8%)
Size of pancreatic stent (paediatric feeding tube)
3 French 1 (2.2%)
5 French 18 (40.0%)
8 French 26 (57.8%)
Volume of external pancreatic drainage, mL/day
Mean 225 ± 114
Median 200
Range 80–600
Duration of pancreatic stent, d
Mean 37 ± 20
Median 35
Range 15–107
*χ2 test. NS = not significant.
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had to wait until the anchoring sutures dissolved, which
in our experience, took longer than 3 weeks.
Despite the superior outcome of the stented patients,
we have to accept that the main drawback of this study is
its non-randomized design. A recent prospective random-
ized trial has been carried out in Hong Kong, and the
results also support the use of external drainage of the
pancreatic duct to reduce pancreaticojejunostomy leak-
age after PD.28 Furthermore, since our study lasted for 17
years, some factors may have strongly influenced the out-
come and may be considered potential pitfalls of this
study. We prefer performing end-to-end pancreaticojeju-
nal anastomosis to other methods of management of the
pancreatic stump because we believe that it is safe and can
be performed easily. Last but not least, refinements of 
the surgical techniques and increasing experience of the
surgical team are unquestionably important factors that
contributed to a better outcome in the stented patients.
External drainage of the pancreatic remnant after PD
is a practical and effective adjunct for prevention of pan-
creaticojejunal anastomotic leakage. When pancreatic fis-
tula occurs after stent insertion, it is usually uncomplicated
and can be treated successfully by conservative means. 
We recommend its routine use in patients who undergo PD,
especially in centres with a low or medium surgical volume.
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